WOOJUNG BIO Inc - Asset Resilience Ratio

Latest as of March 2026: 29.05%

WOOJUNG BIO Inc (215380) has an Asset Resilience Ratio of 29.05% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 215380 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩35.33 Billion

≈ $23.94 Million USD Cash + Short-term Investments

Total Assets

₩121.62 Billion

≈ $82.42 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how WOOJUNG BIO Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see WOOJUNG BIO Inc balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down WOOJUNG BIO Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 215380 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩35.33 Billion	29.05%
Total Liquid Assets	₩35.33 Billion	29.05%

Asset Resilience Insights

Very High Liquidity: WOOJUNG BIO Inc maintains exceptional liquid asset reserves at 29.05% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

WOOJUNG BIO Inc Industry Peers by Asset Resilience Ratio

Compare WOOJUNG BIO Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for WOOJUNG BIO Inc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for WOOJUNG BIO Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.33%	₩285.00 Million ≈ $193.14K	₩86.80 Billion ≈ $58.82 Million	+0.07pp
2024-12-31	0.26%	₩248.30 Million ≈ $168.27K	₩94.70 Billion ≈ $64.18 Million	+0.11pp
2023-12-31	0.15%	₩150.00 Million ≈ $101.65K	₩98.33 Billion ≈ $66.64 Million	-4.92pp
2022-12-31	5.07%	₩4.82 Billion ≈ $3.27 Million	₩94.99 Billion ≈ $64.38 Million	-1.66pp
2021-12-31	6.74%	₩6.74 Billion ≈ $4.57 Million	₩100.14 Billion ≈ $67.86 Million	-15.88pp
2020-12-31	22.62%	₩15.79 Billion ≈ $10.70 Million	₩69.82 Billion ≈ $47.31 Million	-3.93pp
2019-12-31	26.55%	₩15.30 Billion ≈ $10.37 Million	₩57.63 Billion ≈ $39.06 Million	-12.30pp
2018-12-31	38.85%	₩17.41 Billion ≈ $11.80 Million	₩44.81 Billion ≈ $30.37 Million	+4.06pp
2017-12-31	34.80%	₩10.93 Billion ≈ $7.40 Million	₩31.40 Billion ≈ $21.28 Million	-64.24pp
2016-12-31	99.04%	₩11.88 Billion ≈ $8.05 Million	₩12.00 Billion ≈ $8.13 Million	--

pp = percentage points

About WOOJUNG BIO Inc

KQ:215380 Korea Biotechnology

Market Cap

$24.40 Million

₩36.01 Billion KRW

Market Cap Rank

#24556 Global

#1757 in Korea

Share Price

₩2160.00

Change (1 day)

+1.89%

52-Week Range

₩1629.00 - ₩3605.00

All Time High

₩13450.00